Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection
Min Woo Kim, Haein Moon, Sung Jae Yang, Soo Geun Joe
Korean J Ophthalmol. 2016;30(1):25-31.   Published online 2016 Jan 21     DOI: https://doi.org/10.3341/kjo.2016.30.1.25
Citations to this article as recorded by Crossref logo
Posterior sub-tenon injection of triamcinolone in non-resolving vitreoretinitis - A case report
K Shruthi
Journal of Clinical Research and Ophthalmology.2024; 11(1): 005.     CrossRef
Persistent diabetic macular edema: Definition, incidence, biomarkers, and treatment methods
Osama A. Sorour, Emily S. Levine, Caroline R. Baumal, Ayman G. Elnahry, Phillip Braun, Jessica Girgis, Nadia K. Waheed
Survey of Ophthalmology.2023; 68(2): 147.     CrossRef
Optimizing treatment for diabetic macular edema during cataract surgery
Leo Ka Yu Chan, Sui Sum Lin, Fiona Chan, Danny Siu-Chun Ng
Frontiers in Endocrinology.2023;[Epub]     CrossRef
Optical coherence tomography biomarkers after intravitreal triamcinolone acetonide in patients with diabetic macular edema
MariaJoão Matias, Vítor Miranda, CatarinaPestana Aguiar, Lilianne Duarte
The Pan-American Journal of Ophthalmology.2023; 5(1): 10.     CrossRef
Choroidal Structural Changes of Posterior Subtenon Triamcinolone Acetonide Injection in Eyes with Refractory Diabetic Macular Edema
Bing Liu, Guangfeng Ma, Jing Hou, Chenyang Cong, Zeynep Alkin
Journal of Ophthalmology.2022; 2022: 1.     CrossRef
Optical Coherence Tomography Angiography in Refractory Diabetic Macular Edema
Hak Jun Lee, Daniel Duck-Jin Hwang
Journal of Retina.2022; 7(1): 9.     CrossRef
Optical Coherence Tomography Reflectivity in Foveal Cysts: A Novel Biomarker for Early-Response Prediction of Diabetic Macular Edema Treated with Dexamethasone
Daniel Duck-Jin Hwang
Life.2022; 12(10): 1475.     CrossRef
Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives
Sherif A. Gaballa, Uday B. Kompella, Omar Elgarhy, Ali M. Alqahtani, Barbara Pierscionek, Raid G. Alany, Hamdy Abdelkader
Drug Delivery and Translational Research.2021; 11(3): 866.     CrossRef
Current Concepts in Myopic Choroidal Neovascularization: a Review
Dong Hyun Lee, Eun Young Choi, Hyun Goo Kang, Min Kim
Journal of Retina.2020; 5(1): 1.     CrossRef
Intravitreal Triamcinolone Injection in Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection: Clinical Characteristics According to Response
Mihyun Choi, Seong-Woo Kim
Journal of Retina.2020; 5(1): 12.     CrossRef
The effects of intravitreal triamcinolone acetonide in diabetic macular edema refractory to anti-VEGF treatment
In Hwan Hong, Wonseok Choi, Jae Ryong Han
Japanese Journal of Ophthalmology.2020; 64(2): 196.     CrossRef
Characteristics of diabetic macular edema patients refractory to anti-VEGF treatments and a dexamethasone implant
Moon Young Choi, Donghyun Jee, Jin-woo Kwon, Demetrios G. Vavvas
PLOS ONE.2019; 14(9): e0222364.     CrossRef
Treatment outcomes and predicting factors for diabetic macular edema treated with ranibizumab – One-year real-life results in Taiwan
Tso-Ting Lai, Chung-May Yang, Chang-Hao Yang, Tzyy-Chang Ho, Yi-Ting Hsieh
Journal of the Formosan Medical Association.2019; 118(1): 194.     CrossRef
Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema
Seung-Young Yu, Dong Heun Nam, Dae Yeong Lee
Graefe's Archive for Clinical and Experimental Ophthalmology.2018; 256(1): 39.     CrossRef